Stock Events

Stock Events

SynCore Biotechnology 

TWD18.90
0
+TWD0.40+2.16% Friday 05:30

Statistics

Day High
18.3
Day Low
18.3
52W High
29.65
52W Low
18.05
Volume
1,001
Avg. Volume
-
Mkt Cap
664.62M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-232.6%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
23.34MRevenue
-54.28MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

SynCore Biotechnology Co.,Ltd, a Taiwan-based enterprise, specializes in the development and commercialization of biotechnology services, alongside offering expertise in food advisory and medicine inspection. The company's robust pipeline includes several promising drug candidates. Among its novel chemical entities (NCEs), SB01 is an injectable anti-cancer compound currently undergoing Phase II clinical trials for head and neck cancer. Another anti-cancer NCE, SB02, is in preclinical development, targeting stomach cancer. Beyond novel compounds, SynCore also markets established pharmaceutical solutions. This includes SB03-Veregen, an ointment prescribed for external genital and perianal warts. Its portfolio further extends to SB04, a conventional medication for age-related macular degeneration, presently in Phase II clinical studies. Additionally, SynCore is advancing SB05-EndoTAG, an established drug undergoing Phase III clinical trials for the treatment of both pancreatic cancer and triple-negative breast cancer. In a related venture, the company distributes epiCam brand cameras, which are designed for recording the progression of ophthalmic diseases. SynCore maintains strategic collaborations with notable entities such as Medigene AG, MacuCLEAR Inc., Sinphar Pharmaceutical Co., Ltd., and The National Health Research Institutes. Founded in 2008, SynCore Biotechnology Co.,Ltd is headquartered in Yilan City, Taiwan, and operates as a subsidiary of Sinphar Pharmaceutical Co., Ltd.
Show more...
CEO
Chih-Wen Lee
Employees
40
Country
Taiwan
ISIN
TW0004192000

Listings

TWO
TW
4192.TWO

0 Comments

Share your thoughts

FAQ

What is SynCore Biotechnology stock price today?▼
The current price of 4192.TWO is TWD18.90 TWD — it has increased by +2.16% in the past 24 hours. Watch SynCore Biotechnology stock price performance more closely on the chart.
What is SynCore Biotechnology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange SynCore Biotechnology stocks are traded under the ticker 4192.TWO.
Is SynCore Biotechnology stock price growing?▼
4192.TWO stock has fallen by -0.79% compared to the previous week, the month change is a -1.56% fall, over the last year SynCore Biotechnology has showed a -29.61% decrease.
What is SynCore Biotechnology market cap?▼
Today SynCore Biotechnology has the market capitalization of 664.62M
What is SynCore Biotechnology revenue for the last year?▼
SynCore Biotechnology revenue for the last year amounts to 23.34M TWD.
What is SynCore Biotechnology net income for the last year?▼
4192.TWO net income for the last year is -54.28M TWD.
How many employees does SynCore Biotechnology have?▼
As of September 05, 2026, the company has 40 employees.
In which sector is SynCore Biotechnology located?▼
SynCore Biotechnology operates in the Health & Wellness sector.
When did SynCore Biotechnology complete a stock split?▼
SynCore Biotechnology has not had any recent stock splits.
Where is SynCore Biotechnology headquartered?▼
SynCore Biotechnology is headquartered in Yilan City, Taiwan.